Skip to main content
. Author manuscript; available in PMC: 2018 Mar 12.
Published in final edited form as: JCO Clin Cancer Inform. 2017 Jun 8;2017:10.1200/CCI.16.00045. doi: 10.1200/CCI.16.00045

Table 5.

Discrepancy Analysis

Patient Case Risk Notes
NLP Manual Review (gold standard) Clinical Review
1 Intermediate Low Intermediate Discrepancy in Gleason score and PSA; manual review used OSH pathology Gleason (3 + 3 = 6), which was upgraded at VUMC to 3 + 4 = 7
2 Intermediate Low Intermediate Discrepancy in Gleason score; manual review used OSH pathology Gleason (3 + 3 = 6), which was upgraded at VUMC to 3 + 4 = 7
3 High Low Low Discrepancy in Gleason score; pathology note details why this patient case should be treated as 3 + 3 = 6 as opposed to 4 + 4 = 8; NLP algorithm parsed 4 + 4 = 8 from this discussion
4 Intermediate Low Intermediate Discrepancy in PSA; clinical note: “prebiopsy PSA of 20 but then decreased to 5”
5 Low Intermediate Low Discrepancy in Gleason score; manual review used OSH pathology Gleason score (4 + 3 = 7), which was downgraded at VUMC to 3 + 3 = 6
6 Low Intermediate Low Discrepancy in Gleason score; manual review used OSH pathology Gleason score (3 + 4 = 7), which was downgraded at VUMC to 3 + 3 = 6
7 High Intermediate High Discrepancy in Gleason score; manual review used OSH pathology Gleason (4 + 3 = 7), which was upgraded at VUMC to 4 + 4 = 8
8 High High High Inconsequential discrepancy in Gleason score; VUMC pathology: 3 + 5 = 8; OSH pathology: 4 + 3 = 7
9 Intermediate High High Discrepancy in Gleason score; NLP erroneously pulled 4+3=7 instead of 3+5=8
10 Intermediate High High Discrepancy in clinical T stage; clinical note mentioned “some bilateral induration of the prostate and a little bit of nodularity … impression: stage T2c carcinoma of the prostate,” but clinical staging form recorded T1c, which is what NLP extracted

Abbreviations: NLP, natural language processing; OSH, outside hospital; PSA, prostate-specific antigen; VUMC, Vanderbilt University Medical Center.